Advertisement

Picture [iito] No Tracking 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in France and Monaco or involving organisations from these countries.

Total search results: 2020 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
F2G Ltd–Novo Group: investment, 202208 financing round totalling $70m inc existing + co-investor Novo Holdings 2022-08-04
F2G Ltd–SEVERAL: investment, 202208 financing round $70m co-led by new investors Forbion + Sofinnova Partners 2022-08-04
F2G Ltd–Sofinnova: investment, 202208 financing round totalling $70m inc new + co-lead investor Sofinnova Partners 2022-08-04
Forty51 Ventures–Fischli Group: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor Fischli Family 2022-07-18
Forty51 Ventures–OTHER: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl biotech entrepreneures + private individuals 2022-07-18
Forty51 Ventures–SEVERAL: investment, 202207 first $43m closing of Forty51 Ventures I fund 2022-07-18
Forty51 Ventures–Stable Asset Management: investment, 202207 first closing totalling $43m of Forty51 Ventures I fund incl co-lead investor SAM 2022-07-18
Agomab Therapeutics–OTHER: investment, 202207 financing round Series B extension totalling $40.5m incl existing-investors 2022-07-13
Agomab Therapeutics–SEVERAL: investment, 202207 financing round Series B extension $40.5m led by Pfizer bringing total Series B to $114m 2022-07-13
Biosyntia–ECBF: investment, 202207 financing round Series B totalling €11.5m incl new + lead investor ECBF 2022-07-07
Biosyntia–Novo Group: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Novo Seeds 2022-07-07
Biosyntia–SEVERAL: investment, 202207 financing round Series B €11.5m led by new investor ECBF 2022-07-07
Biosyntia–Sofinnova: investment, 202207 financing round Series B totalling €11.5m incl existing + co-investor Sofinnova Partners 2022-07-07
Ganymed Robotics–BNP Paribas: investment, 202207 financing round Series B first closing totalling €21m incl co-investor BNP Paribas Développement 2022-07-07
Ganymed Robotics–Cathay Capital: investment, 202207 financing round Series B first closing totalling €21m incl lead investor Cathay Health 2022-07-07
Ganymed Robotics–Crédit Mutuel-CIC: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Crédit Mutuel Innovation 2022-07-07
Ganymed Robotics–Eurazeo: investment, 202207 financing round Series B first closing totalling €21m incl co-investor Kurma Partners 2022-07-07
Ganymed Robotics–OTHER: investment, 202207 financing round Series B first closing totalling €21m incl internationallly renowned surgeons 2022-07-07
Ganymed Robotics–SEVERAL: investment, 202207 financing round Series B first closing €21m led by Cathay Health 2022-07-07
Aurobac Therapeutics–Boehringer: investment, 202207 launch of €40m joint venture Aurobac incl €30m from lead investor Boehringer Ingelheim 2022-07-06
Boehringer–Evotec: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor Evotec 2022-07-06
Boehringer–Mérieux: investment, 202207 launch of €40m joint venture Aurobac incl €5m from co-investor bioMérieux 2022-07-06
Epizyme–Ipsen: investment, 202206– cash tender offer $247m + 1CVR/share ANNOUNCED 2022-06-27
Micropep Technologies–CEA Industrie: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Supernova Invest 2022-06-27
Micropep Technologies–Fall Line Capital: investment, 202206 financing round Series A1 totalling €8.75m incl new + lead investor Fall Line Capital 2022-06-27
Micropep Technologies–FMC: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor FMC Ventures 2022-06-27
Micropep Technologies–Irdi Soridec: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Irdi/Soridec 2022-06-27
Micropep Technologies–SEVERAL: investment, 202206 financing round Series A1 €8.75m led by new investor Fall Line Capital 2022-06-27
Micropep Technologies–Sofinnova: investment, 202206 financing round Series A1 totalling €8.75m incl existing + co-investor Sofinnova Partners 2022-06-27
Kranus Health–Karista: investment, 202206 financing round Series A totalling >$6.5m incl lead investor Karista 2022-06-20
Kranus Health–SEVERAL: investment, 202206 financing round Series A >$6.5m led by Karista 2022-06-20
Valneva–Pfizer: investment, 202206 equity investment via capital increase €90.5m (representing 8.1% if capital) at €9.49/share 2022-06-20
ImCheck Therapeutics–Agent Capital: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Agent Capital 2022-06-13
ImCheck Therapeutics–Alexandria Real Estate: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Alexandria VI 2022-06-13
ImCheck Therapeutics–Andera Partners: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Andera Partners 2022-06-13
ImCheck Therapeutics–Bellevue: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Pureos Bioventures 2022-06-13
ImCheck Therapeutics–Boehringer: investment, 202206 financing round Series C totalling €80m incl existing + co-investor BIVF 2022-06-13
ImCheck Therapeutics–Earlybird: investment, 202206 financing round Series C totalling €80m incl new + co-lead investor Earlybird 2022-06-13
ImCheck Therapeutics–EQT: investment, 202206 financing round Series C totalling €80m incl existing + co-investor EQT Life Sciences 2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Eurazeo 2022-06-13
ImCheck Therapeutics–Eurazeo: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Kurma Partners GO Fund 2022-06-13
ImCheck Therapeutics–France (govt): investment, 202206 financing round Series C totalling €80m incl existing + co-investor Bpifrance Innobio 2 + LV 2022-06-13
ImCheck Therapeutics–Gimv: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Gimv 2022-06-13
ImCheck Therapeutics–Invus Group: investment, 202206 financing round Series C totalling €80m incl new + co-investor Invus 2022-06-13
ImCheck Therapeutics–Leukemia & Lymphoma Society: investment, 202206 financing round Series C totalling €80m incl new + co-investor LLS TAP 2022-06-13
ImCheck Therapeutics–Pfizer: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Pfizer Ventures 2022-06-13
ImCheck Therapeutics–SEVERAL: investment, 202206 financing round Series C €80m co-led by new investors Earlybird + Andera Partners 2022-06-13
ImCheck Therapeutics–Wellington Partners: investment, 202206 financing round Series C totalling €80m incl existing + co-investor Wellington Partners 2022-06-13
Ariceum Therapeutics–Optimum Strategic Communications: public relations, 202206 service existent by Optimum 2022-06-08
Ariceum Therapeutics–SEVERAL: investment, 202206 financing round Series A €25m co-led by HealthCap + EQT Life Sciences 2022-06-08
Weezion–Mérieux: in-vitro diagnostics, 202206– collab technical assistance from bioMérieux to develop MS-based sepsis IVD 2022-06-01
Weezion–Mérieux: investment, 202206 investment €2m from bioMérieux for a 4.26% share accompanied by technical assistance 2022-06-01
Minoryx–SEVERAL: credit, 202205 complementary bank debt to Series C financing round (both tog totalling €51m) 2022-05-31
Minoryx–SEVERAL: investment, 202205 financing round Series C (incl complementary bank totalling €51m) led by Columbus VP + Caixa Capital Risc 2022-05-31
Repertoire Genesis–Eurofins: investment, 202205 acquisition of majority stake by Eurofins Scientific 2022-05-31
Advent Life Sciences–Scius Communications: public relations, 202205 supply service existent by Scius Communications 2022-05-26
Apollo Global Management–Sofinnova: life science financing, 202205– strategic partnership incl investm in Sofinnova Partners + up to $1b capital 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– acquisition of minority equity interest in Sofinnova Partners as part of strategic partnership 2022-05-16
Sofinnova–Apollo Global Management: investment, 202205– commitment of up to $1b managed capital to Sofinnova Partners investment funds by Apollo 2022-05-16
NanoPhoria–Sofinnova: investment, 202205 seed financing €3.5m from Sofinnova Telethon Fund 2022-05-12
Domain Therapeutics–BPCE: investment, 202205 financing round Series A totalling €39m incl existing + co-investor Seventure Partners 2022-05-10
Domain Therapeutics–Canada (govt): investment, 202205 financing round Series A totalling €39m incl co-investor adMare BioInnovations 2022-05-10
Domain Therapeutics–CTI Life Sciences: investment, 202205 financing round Series A totalling €39m incl co-lead investor CTI Life Sciences 2022-05-10
Domain Therapeutics–Helsinn: investment, 202205 financing round Series A totalling €39m incl co-lead investor 3B Future Health Fund 2022-05-10
Domain Therapeutics–Omnes Capital: investment, 202205 financing round Series A totalling €39m incl co-investor Omnes 2022-05-10
Domain Therapeutics–Panacea Venture: investment, 202205 financing round Series A totalling €39m incl co-lead investor Panacea Venture 2022-05-10
Domain Therapeutics–Schroders: investment, 202205 financing round Series A totalling €39m incl co-investor Schroders Capital 2022-05-10
Domain Therapeutics–SEVERAL: investment, 202205 financing round Series A €39m co-led by Panacea Venture + CTI Life Sciences + 3B Future Health Fund 2022-05-10
Domain Therapeutics–Theodorus: investment, 202205 financing round Series A totalling €39m incl co-investor Theodorus 2022-05-10
Domain Therapeutics–Turenne: investment, 202205 financing round Series A totalling €39m incl co-investor Turenne Capital/Sham Innovation Santé 2022-05-10
Domain Therapeutics–Viva Biotech: investment, 202205 financing round Series A totalling €39m incl co-investor Viva BioInnovator 2022-05-10
Tubulis–Andera Partners: investment, 202205 financing round Series B totalling €60m incl new + lead investor Andera Partners 2022-05-03
Tubulis–BPCE: investment, 202205 financing round Series B totalling €60m incl existing + co-investor Seventure Partners 2022-05-03
Tubulis–SEVERAL: investment, 202205 financing round Series B €60m led by new investor Andera Partners 2022-05-03
OMass–SEVERAL: investment, 202204 financing round Series B £75.5m led by new investors GV + Northpond Ventures + Sanofi Ventures 2022-04-28
Peak Proteins–Sygnature Discovery: investment, 202204 acquisition €na of Peak Proteins by Sygnature Discovery 2022-04-26
CDR-Life–Jeito Capital: investment, 202204 financing round Series A totalling $76m incl co-lead investor Jeito Capital 2022-04-13
CDR-Life–SEVERAL: investment, 202204 financing round Series A $76m co-led by Jeito Capital + RA Capital 2022-04-13
Ribonexus–France (govt): credit, 202204– repayable advance €1.4m via Future Investments Program from Bpifrance 2022-04-12
Ribonexus–France (govt): grant, 202204– grant €600k via Future Investments Program from Bpifrance 2022-04-12
Carmat–SEVERAL: investment, 202204 global offering €40.5m via issuance of 4.05m new shares 2022-04-11
LimFlow–Balestier: investment, 202204 financing round Series D totalling €36m incl existing investor Balestier family fund 2022-04-06
LimFlow–France (govt): investment, 202204 financing round Series D totalling €36m incl existing investor Bpifrance 2022-04-06
LimFlow–Longitude Capital: investment, 202204 financing round Series D totalling €36m incl new investor Longitude Capital 2022-04-06
LimFlow–OTHER: investment, 202204 financing round Series D totalling €36m incl new undisclosed strategic investor 2022-04-06
LimFlow–SEVERAL: investment, 202204 financing round Series D €36m with new + existing investors 2022-04-06
LimFlow–Sofinnova: investment, 202204 financing round Series D totalling €36m incl existing investor Sofinnova Partners 2022-04-06
LimFlow–Soleus Capital: investment, 202204 financing round Series D totalling €36m incl new investor Soleus Capital 2022-04-06
Bio-Medical Science–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Bio-Medical Science in Korea 2022-04-05
Cold Spring Biotech–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Cold Spring in China, Taiwan + Hong Kong 2022-04-05
Premas Life Sciences–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Premas Life Sciences in India 2022-04-05
Research Instruments (SG)–DNA Script: DNA synthesis system, 202204– distribution of Syntax EDS System by Research Instruments in Singapore 2022-04-05
CardioRenal–SEVERAL: investment, 202204 seed financing round €3.3m from businses angels + management 2022-04-04
Axa–Canary Wharf Group: real estate, 202203– collab joint venture of Kadans Science Partner + CWG to built wet lab buliding in Canary Wharf London 2022-03-30
Core Biogenesis–Blue Horizon Ventures: investment, 202203 financing round Series A totalling €10m incl new + co-lead investor Blue Horizon Ventures 2022-03-29
Core Biogenesis–Entrepreneur First: investment, 202203 financing round Series A totalling €10m incl existing + co-investor Entrepreur First 2022-03-29
Core Biogenesis–OTHER: investment, 202203 financing round Series A totalling €10m incl business angels as investors 2022-03-29
Core Biogenesis–SEVERAL: investment, 202203 financing round Series A €10m led by XAnge + Blue Horizon Ventures 2022-03-29
Core Biogenesis–Siparex: investment, 202203 financing round Series A totalling €10m incl existing + co-lead investor XAnge 2022-03-29
Sanofi–IGM Biosciences: IgM antibody agonists, 202203– collab RnD + commerc ww excl $150m upfront + >$6b milestones for cancer + inflammation 2022-03-29
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21  next pagenext page



Advertisement

Picture [iito] No Tracking 650x100px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top